The U.S. Food and Drug Administration has approved Johnson & Johnson's drug to treat some patients aged 12 years and older ...

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

Heeding the call to ban artificial ingredients by Health and Human Services Secretary Robert F. Kennedy Jr., PepsiCo isn’t ...

One of America's leading surgeons has warned men against taking a hair-loss drug linked to permanent genital side effects.

The officials stopped short of promising a formal ban and offered few specifics on how they intended to achieve the sweeping ...

Future of Healthcategory· April 18, 2025 Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients are found in: The drug products were in shortage since 2020. The FDA had ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.